PharmaSource: The External Manufacturing Community Essential intelligence for biopharma outsourcing leaders | Trusted by 70,000+ professionals | Subscribe TOP STORIES Supplier Management Has a People Problem, 2026 Research Finds Read More » Hikal Signs Multi-Year CDMO Agreement With European Agrochemical Firm After Nearly Three Years of Joint Development Akums Posts 31.9% Revenue Growth in Q2 FY27 as CDMO Volumes Drive Outsourcing Expansion Shilpa CDMO Invests $50M to Scale Peptide Manufacturing, With First Commercial Line Opening December 2026 Coriolis Pharma Appoints Dr. Teun van der Heide as CEO AKEURA Launches as Specialist CRO Combining Clinical Development and Real-World Evidence After P95 and Julius Clinical Integration Laurus Labs Acquires 60% Stake in Galenvs Science for $3.75 Million Fresenius Signs WuXi Biologics Agreement to Access Up to 37 Biosimilar Candidates Cambrex Breaks Ground on $120M Expansion to Add 160,000 Liters of API Capacity AnaCipher Receives ANVISA Brazil Approval for Clinical and Bioanalytical Facilities to Support BA/BE Studies for Brazilian Submissions Pace Life Sciences Completes EMA GMP Inspection at New Jersey Facility Altruist Biologics Secures NMPA Priority Review for Localized Biologic Drug Manufacturing Asymchem Completes First USFDA Pre-Approval Inspection at Tianjin TIDES Facility Codis Begins Construction on PSD-4 Expansion to Increase Spray Drying Capacity Lonza Expands Bioconjugation Manufacturing Capacity in Visp with Three New Suites From Development to Commercial Reality: Building Scalable Biologics Processes from the Start More news + insights Hikal Signs Multi-Year CDMO Agreement With European Agrochemical Firm After Nearly Three Years of Joint Development Akums Posts 31.9% Revenue Growth in Q2 FY27 as CDMO Volumes Drive Outsourcing Expansion Shilpa CDMO Invests $50M to Scale Peptide Manufacturing, With First Commercial Line Opening December 2026 PODCASTS “You Can’t Have Your Cake and Eat It”: Pfizer, Biogen, Astellas and ROIS on Network Strategy in an Uncertain Landscape State of the Industry: Five Takeaways on Tariffs, Reshoring, China and Talent from CDMO Live Americas 2026 SPOTLIGHT Bridging Studies for AAV Producer Cell Line Adoption [Whitepaper] RESOURCES AI + Digital Maturity in Contract Manufacturing 2026: Report and Exclusive Webinar AI Pilots and Strategic Partnerships: ExM Leaders Basel 2026 Report Bridging Studies for AAV Producer Cell Line Adoption [Whitepaper] UPCOMING EVENTS AI + Digital Maturity in Contract Manufacturing 2026: Report and Exclusive Webinar MASTERCLASS: De-Risking Technology Transfer in OSD External Manufacturing Leaders West 2027 External Manufacturing Leaders Dublin 2026
Hikal Signs Multi-Year CDMO Agreement With European Agrochemical Firm After Nearly Three Years of Joint Development
Shilpa CDMO Invests $50M to Scale Peptide Manufacturing, With First Commercial Line Opening December 2026
AKEURA Launches as Specialist CRO Combining Clinical Development and Real-World Evidence After P95 and Julius Clinical Integration
AnaCipher Receives ANVISA Brazil Approval for Clinical and Bioanalytical Facilities to Support BA/BE Studies for Brazilian Submissions
Hikal Signs Multi-Year CDMO Agreement With European Agrochemical Firm After Nearly Three Years of Joint Development
Shilpa CDMO Invests $50M to Scale Peptide Manufacturing, With First Commercial Line Opening December 2026
“You Can’t Have Your Cake and Eat It”: Pfizer, Biogen, Astellas and ROIS on Network Strategy in an Uncertain Landscape
State of the Industry: Five Takeaways on Tariffs, Reshoring, China and Talent from CDMO Live Americas 2026